Metabolism
Purity: 99.3%
Tirzepatida
High-purity dual GIP/GLP-1 agonist.
Description
Tirzepatide activates GIP and GLP-1 receptors simultaneously, making it a compound of interest for comparative studies of metabolic efficacy against single-receptor agonists. Available in several presentations depending on the protocol's required dose.
Tested batches (COA)
| Batch number | Purity | Tested on |
|---|---|---|
| Novalabs-2026-0049 | 99.3% | 2026-08-12 |